Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01312519
Other study ID # 2007-04
Secondary ID
Status Completed
Phase N/A
First received November 3, 2010
Last updated July 29, 2013
Start date January 2010
Est. completion date August 2010

Study information

Verified date July 2013
Source Vidacare Corporation
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review BoardSpain: Ethics Committee
Study type Interventional

Clinical Trial Summary

This is a randomized study evaluating use of a powered bone marrow biopsy and aspiration system (OnControl by Vidacare) compared to traditional manual devices. The hypothesis is that the powered system will reduce the level of patient pain during the aspiration and core biopsy procedures and the amount of time needed to perform the procedures.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date August 2010
Est. primary completion date July 2010
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adults over the age of 18

- Patients that require core biopsy alone, or core biopsy and bone marrow aspiration

Exclusion Criteria:

- Imprisoned

- Pregnant

- Cognitively impaired

- Requiring english language translation other than Spanish

- Patients with one or more conditions precluding bone marrow core biopsy

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Device:
OnControl Bone Marrow Biopsy and Aspiration System
Battery powered device used for insertion of a single lumen catheter into the intraosseous space of the adult iliac crest for the purpose of aspiration and core biopsy collection.
Manual bone marrow sampling device
Hollow needle with a t-shaped handle that is pushed into the bone for the purpose of collecting bone marrow aspiration and core biopsy samples.

Locations

Country Name City State
Spain Hospital General Universitario Gregorio Maranon Madrid
United States Cancer Therapy and Research Center San Antonio Texas

Sponsors (1)

Lead Sponsor Collaborator
Vidacare Corporation

Countries where clinical trial is conducted

United States,  Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Subject Reported Level of Pain During Procedure Subjects were asked to rate the level of pain they experienced during the procedure for needle insertion, following penetration of the cortex. A 0 to 10 pain scale was used where 0=no pain and 10= worst possible pain. Day 1 during the needle insertion No
Secondary Time Necessary to Perform the Bone Marrow Procedure The time necessary to perform the procedure was measured as follows: Time started once the needle and skin came into contact and time stopped once the sample was collected and the needle was removed from the patient. Day 1 needle insertion through needle removal No